ArticleOncotarget2016
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
Mei-Ren Pan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it